Login to Your Account

Financings Roundup

Wednesday, March 23, 2011
Stem Cell Therapeutics Corp., of Calgary, Alberta, said it grossed $2 million by selling about 18.18 million units, consisting of one common share and a warrant for one-half of a common share, at 11 cents per unit. Each warrant can be exercised within three years at a price of 16 cents.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription